Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Behr, Jürgen [VerfasserIn]   i
 Kreuter, Michael [VerfasserIn]   i
 Herth, Felix [VerfasserIn]   i
Titel:Management of patients with idiopathic pulmonary fibrosis in clinical practice
Titelzusatz:the INSIGHTS-IPF registry
Verf.angabe:Jürgen Behr, Michael Kreuter, Marius M. Hoeper, Hubert Wirtz, Jens Klotsche, Dirk Koschel, Stefan Andreas, Martin Claussen, Christian Grohé, Henrike Wilkens, Winfried Randerath, Dirk Skowasch, F. Joachim Meyer, Joachim Kirschner, Sven Gläser, Felix J.F. Herth, Tobias Welte, Rudolf Maria Huber, Claus Neurohr, Martin Schwaiblmair, Martin Kohlhäufl, Gert Höffken, Matthias Held, Andrea Koch, Thomas Bahmer, David Pittrow
E-Jahr:2015
Jahr:July 2015
Umfang:11 S.
Fussnoten:Gesehen am 31.03.2017
Titel Quelle:Enthalten in: The European respiratory journal
Ort Quelle:Lausanne : ERS, 1988
Jahr Quelle:2015
Band/Heft Quelle:46(2015), 1, Seite 186-196
ISSN Quelle:1399-3003
Abstract:After introduction of the new international guidelines on idiopathic pulmonary fibrosis (IPF) in 2011, we investigated clinical management practices for patients with IPF according to physicians' diagnoses., A prospective, multicenter, noninterventional study with comprehensive quality measures including on-site source data verification was performed in Germany., 502 consecutive patients (171 newly diagnosed, 331 prevalent; mean±sd age 68.7±9.4 years, 77.9% males) with a mean disease duration of 2.3±3.5 years were enrolled. IPF diagnosis was based on clinical assessments and high-resolution computed tomography (HRCT) in 90.2%, and on surgical lung biopsy combined with histology in 34.1% (lavage in 61.8%). The median 6-min walk distance was 320 m (mean 268±200 m). The mean forced vital capacity was 72±20% pred and diffusing capacity of the lung for carbon monoxide was 35±15% pred. No drugs were administered in 17.9%, oral steroids in 23.7%, N-acetylcysteine in 33.7%, pirfenidone in 44.2% and other drugs in 4.6% of patients. Only 2.8% of the cohort was listed for lung transplantation., IPF patients were diagnosed in line with the new guidelines. They had more severe disease than those enrolled in recent randomised controlled trials. In addition to HRCT, the frequency of lung biopsies was surprisingly high. Treatment patterns varied substantially., This largest published registry of IPF patients shows surprising disease severity and treatment variation http://ow.ly/JbWRn
DOI:doi:10.1183/09031936.00217614
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

kostenfrei: Volltext: http://dx.doi.org/10.1183/09031936.00217614
 kostenfrei: Volltext: https://erj.ersjournals.com/content/46/1/186
 DOI: https://doi.org/10.1183/09031936.00217614
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1556147325
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68105189   QR-Code
zum Seitenanfang